Valar Doeharis: Arya Sciences Acquisition Corp. Files for $125M SPAC
by Kristi Marvin on 2018-09-12 at 0:26am


Winter is Coming and so is Arya Sciences Acquisition Corp.

Arya Sciences Acquisition Corp. filed for a $125 million SPAC IPO today, with a focus on the healthcare, and more specifically, the life sciences and medical technology sectors.  Additionally, Perceptive Advisors,  one of the most well known life sciences hedge funds, is acting as sponsor.

Arya Sciences is being led by Joseph Edelman, the founder of Perceptive Advisors, as Chairman, and Adam Stone, who is the Chief Investment Officer of Perceptive, as CEO and Director.  If you’re going to be looking in the healthcare space, it’s hard to argue with wanting Perceptive involved.  Perceptive has over $5 billion in assets under management focused exclusively on the healthcare industry so clearly they have some understanding of the sector.

Additionally, Perceptive Advisors will be sponsoring this SPAC via it’s affiliate – Arya Sciences Holdings, and has indicated an interest in purchasing up to $25 million of shares at business combination.  However, an “indication of interest” is sort of like the Coke Zero of backstops.  Tastes like Coke, but without any of the “sugar”.  I.e.,  they say they’re interested, but it doesn’t hold a lot of weight.

A summary of terms has been provided below, but you can review the the profile page with management bios here.

Arya Sciences Summary of Terms:
  • Focus:  Healthcare – Life Sciences/Med Tech
  • Size: $125 million
  • 100.0% held in trust ($10.00 per share)
  • $10.00 unit comprised of one share of Common Stock + 1/2 of a full Warrant 
  • Warrant call for redemption trigger: equals or exceeds $18.00 (cash or cashless exercise)
  • 24 months to complete an acquisition
  • Limitation on Redemption Rights: 15%
  • At-risk Capital: $5.44 million (5,437,500 warrants at $1.00)
  • Indication of Interest: 
    • Arya Science Holdings (an affiliate of Perceptive), the Sponsor, has indicated an interest in purchasing up to $25 million of shares at combination
  • Underwriter fees: 2.75% + 3.25% deferred. 


Jefferies is sole book-running manager and Chardan is lead manager.

Kirkland & Ellis LLP and Skadden, Arps, Slate, Meagher & Flom LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.


Recent Posts
by Nicholas Alan Clayton on 2023-11-30 at 10:10am

Nukkleus (OTC:NUKK) announced “the completion of its strategic merger” with Brilliant (NASDAQ:BRLI) this morning, which has caused some ripples in the market, but it does not appear to represent an actual closing of the business combination. The two sides may have dotted the Is and crossed the Ts on their own internal documents, but Brilliant...

by Marlena Haddad on 2023-11-30 at 9:44am

ClimateRock (NASDAQ: CLRC) announced this morning that it has terminated its business combination with solar plant developer EEW. The SPAC noted that it decided to part ways with its target since the conditions to closing were not satisfied or waived by the outside date of September 30. ClimateRock inked the $650 million deal with EEW in...

by Nicholas Alan Clayton on 2023-11-30 at 9:10am

10x Capital Venture II (NASDAQ:VCXA) filed a variety of changes to its combination with African Agriculture while also postponing its completion vote to 8 am ET December 5. The tweaks waive African Agriculture’s requirement to secure an offtake agreement and also shift 3,000,000 shares to a bonus pool for all combined company shareholders. Of these,...

by Nicholas Alan Clayton on 2023-11-30 at 7:58am

At the SPAC of Dawn Pono Capital Three (NASDAQ:PTHR) is the latest SPAC to try and bring an eVTOL target in for landing, and, as a part of its final flight checks, it dropped its first full investor presentation for its target Horizon yesterday. This included a few updates and new information on how Horizon...

by Marlena Haddad on 2023-11-29 at 5:07pm

CF Acquisition Corp. VIII (NASDAQ:CFFE) announced this afternoon that it has completed its combination with B2B software firm Exela. Although shareholders had previously approved the deal during a special meeting on August 24, no specific timeline for its next steps had been disclosed at that time. Additionally, a proposal was passed at the meeting to change...


Copyright © 2023 SPACInsider, Inc. All Rights Reserved